AudioAbstracts
AudioAbstracts by ReachMD provides an easy-to-digest distillation of important medical literature in combination with digital linkage to in-depth information supporting the audio synopsis.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Sep 1, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 17, 2026
Latest episodes
New Universal Definition Reframes Heart Failure Beyond Ejection Fraction (opens the original)
Read excerpt
Host: Ryan Quigley The 2026 Second Universal Definition of Heart Failure introduces a more dynamic framework that moves beyond fixed ejection fraction thresholds to account for disease trajectory, underlying cause, and clinical context. To learn more, join Ryan Quigley as he reviews the updated approach to ejection fraction, key distinctions between improvement and recovery, and new classifications for heart failure trajectory and cause.
4F-PCC Enables Faster VKA Reversal Before Urgent Orthopedic Surgery (opens the original)
Read excerpt
Host: Matt Birnholz, MD A post hoc analysis of a randomized phase 3b trial evaluated four-factor prothrombin complex concentrate (4F-PCC) versus plasma for urgent vitamin K antagonist (VKA) reversal in adults requiring orthopedic surgery. While both treatments demonstrated comparable hemostatic efficacy and similar safety profiles, 4F-PCC produced substantially faster INR reduction and shortened the median time to surgery by more than 13 hours compared with plasma. These findings add to the grow
Rapid and Sustained Symptom Control in CSU with Remibrutinib (opens the original)
Read excerpt
Despite expanding treatment options, many patients with chronic spontaneous urticaria (CSU) continue to experience persistent itch and hives that can significantly affect their quality of life. Tune in to hear Ryan Quigley review pooled results from the phase 3 REMIX-1 and REMIX-2 studies, highlighting how remibrutinib delivered rapid symptom relief, sustained disease control through one year, and a favorable long-term safety profile for adults with CSU.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.